| Sex |  | ||
---|---|---|---|---|
Variable | Male (n = 468) | Female (n = 180) | Total (N = 648) | |
Demographic | Â | Â | Â | |
Age, n (%) | Â | Â | Â | |
≤ 25 | 206 (44.0%) | 140 (77.8%) | 346 (53.4%) | |
26+ | 262 (56.0%) | 40 (22.2%) | 302 (46.6%) | |
Language, n (%) | Â | Â | Â | |
Swedish | 447 (95.5%) | 107 (59.4%) | 554 (85.5%) | |
English | 21 (4.5%) | 73 (40.6%) | 94 (14.5%) | |
Previous Concussive Events | Â | Â | Â | |
Total | 1.0 [0.0, 3.0] | 0.0 [0.0, 2.0] | 1.0 [0.0, 2.0] | |
0 | 212 (45.8%) | 89 (50.6%) | 301 (47.1%) | |
1–2 | 128 (27.6%) | 55 (31.3%) | 183 (28.6%) | |
3+ | 123 (26.6%) | 32 (18.2%) | 155 (24.3%) | |
Missing, n | 5 | 4 | 9 | |
Current Drug Use | Â | Â | Â | |
Illicit drugs past year, n (V%) | 13 (2.9%) | 16 (9.2%) | 29 (4.6%) | |
Missing, n | 16 | 7 | 23 | |
Analgesics past month, n (V%) | 28 (6.2%) | 5 (2.9%) | 33 (5.3%) | |
Missing, n | 16 | 7 | 23 | |
Soporifics past month, n (V%) | 57 (12.6%) | 24 (13.9%) | 81 (13.0%) | |
Missing, n | 16 | 7 | 23 | |
Psychiatric Diagnoses | Â | Â | Â | |
ADHD/LD Dx, n (V%) | 22 (4.8%) | 29 (16.7%) | 51 (8.1%) | |
Missing, n | 11 | 6 | 17 | |
Psychiatric Dx, n (V%) | 29 (6.3%) | 46 (26.4%) | 75 (11.9%) | |
Missing, n | 11 | 6 | 17 | |
GD Dx, n (V%) | 12 (2.6%) | 0 (0.0%) | 12 (1.9%) | |
Missing, n | 11 | 6 | 17 | |
SUD Dx, n (V%) | 7 (2.1%) | 6 (3.4%) | 13 (1.6%) | |
Missing, n | 11 | 6 | 17 | |
Psychiatric Outcomes | Â | Â | Â | |
Alcohol: AUDIT-C, M ± SD | 4.5 ± 1.8 | 2.7 ± 1.9 | 4.0 ± 2.0 | |
Hazardous consumption, n (V%) | 134 (29.5%) | 63 (36.4%) | 197 (31.4%) | |
Missing, n | 13 | 7 | 20 | |
Social media: BSMAS, Mdn [Q1-Q3] | 4.0 [1.0, 8.0] | 7.0 [3.0, 11.0] | 4.0 [1.0, 9.0] | |
At-risk 14 ≤ 25, n (V%) | 37 (8.2%) | 26 (15.0%) | 63 (10.1%) | |
Problematic use ≥ 26, n (V%) | 0 (0.0%) | 2 (1.2%) | 2 (0.3%) | |
Missing, n | 19 | 7 | 26 | |
Depression: PHQ-9, Mdn [Q1-Q3] | 2.0 [0.0, 3.0] | 4.0 [2.0, 7.0] | 2.0 [0.0, 5.0] | |
Mild 5 ≤ 9, n (V%) | 71 (15.8%) | 55 (31.8%) | 126 (20.2%) | |
Moderate/Severe ≥ 10, n (V%) | 7 (1.6%) | 26 (15.0%) | 33 (5.3%) | |
Missing, n | 18 | 7 | 25 | |
Anxiety: GAD-7, Mdn [Q1-Q3] | 2.0 [0.0, 3.0] | 4.0 [2.0, 7.0] | 2.0 [0.0, 5.0] | |
Mild 5 ≤ 9, n (V%) | 69 (15.3%) | 52 (30.1%) | 121 (19.4%) | |
Moderate/Severe ≥ 10, n (V%) | 7 (1.6%) | 18 (10.4%) | 25 (4.0%) | |
Missing, n | 17 | 7 | 24 | |
Burnout: s-ES, n (V%) | Â | Â | Â | |
At-risk, see caption for conditions* | 29 (6.4%) | 27 (15.6%) | 56 (9.0%) | |
Clinical, A ≥ 2, B ≥ 4, C ≥ 1 | 18 (4.0%) | 33 (19.1%) | 51 (8.2%) | |
Missing, n | 18 | 7 | 25 |